NO20085189L - 2-alkoksy-3,4,5-trihydroksy-alkylamid-benzotaizepiner, fremstilling og anvendelse derav sammensetninger inneholdende samme - Google Patents
2-alkoksy-3,4,5-trihydroksy-alkylamid-benzotaizepiner, fremstilling og anvendelse derav sammensetninger inneholdende sammeInfo
- Publication number
- NO20085189L NO20085189L NO20085189A NO20085189A NO20085189L NO 20085189 L NO20085189 L NO 20085189L NO 20085189 A NO20085189 A NO 20085189A NO 20085189 A NO20085189 A NO 20085189A NO 20085189 L NO20085189 L NO 20085189L
- Authority
- NO
- Norway
- Prior art keywords
- trihydroxyalkylamide
- alkoxy
- preparation
- same
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D281/10—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D281/02—Seven-membered rings
- C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
- C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Foreliggende oppfinnelse angår særlig 2-alkoksy-3,4,5-trihydroksyalkylamidbenzotiazepiner, fremstilling derav, sammensetninger som inneholder samme, og anvendelse derav som medikamenter, særlig antikreftlegemidler.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0604735A FR2901555A1 (fr) | 2006-05-24 | 2006-05-24 | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation |
PCT/FR2007/000867 WO2007135294A2 (fr) | 2006-05-24 | 2007-05-23 | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur préparation, compositions les contenant et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20085189L true NO20085189L (no) | 2009-02-11 |
Family
ID=37496965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20085189A NO20085189L (no) | 2006-05-24 | 2008-12-12 | 2-alkoksy-3,4,5-trihydroksy-alkylamid-benzotaizepiner, fremstilling og anvendelse derav sammensetninger inneholdende samme |
Country Status (31)
Country | Link |
---|---|
US (1) | US7960373B2 (no) |
EP (1) | EP2029596B1 (no) |
JP (1) | JP2009537615A (no) |
KR (1) | KR20090010214A (no) |
CN (1) | CN101454278A (no) |
AR (1) | AR061104A1 (no) |
AT (1) | ATE458738T1 (no) |
AU (1) | AU2007253197A1 (no) |
BR (1) | BRPI0711892A2 (no) |
CA (1) | CA2652361A1 (no) |
CR (1) | CR10428A (no) |
CY (1) | CY1110089T1 (no) |
DE (1) | DE602007004982D1 (no) |
DK (1) | DK2029596T3 (no) |
DO (1) | DOP2007000103A (no) |
EA (1) | EA200870566A1 (no) |
EC (1) | ECSP088897A (no) |
ES (1) | ES2341589T3 (no) |
FR (1) | FR2901555A1 (no) |
GT (1) | GT200800254A (no) |
MA (1) | MA30560B1 (no) |
MX (1) | MX2008014957A (no) |
NO (1) | NO20085189L (no) |
PE (1) | PE20080258A1 (no) |
PL (1) | PL2029596T3 (no) |
PT (1) | PT2029596E (no) |
SI (1) | SI2029596T1 (no) |
TN (1) | TNSN08442A1 (no) |
TW (1) | TW200812990A (no) |
UY (1) | UY30366A1 (no) |
WO (1) | WO2007135294A2 (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2878528B1 (fr) | 2004-11-29 | 2008-05-16 | Aventis Pharma Sa | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4692522A (en) * | 1985-04-01 | 1987-09-08 | Merck & Co., Inc. | Benzofused lactams useful as cholecystokinin antagonists |
US4831135A (en) * | 1986-06-18 | 1989-05-16 | The Regents Of The University Of California | Bengamide anthelmintics |
US5283241A (en) * | 1992-08-28 | 1994-02-01 | Merck & Co., Inc. | Benzo-fused lactams promote release of growth hormone |
GB9411841D0 (en) | 1994-06-14 | 1994-08-03 | Pharma Mar Sa | New antitumoral compounds from jaspis sponge |
JP2002241368A (ja) * | 1997-02-18 | 2002-08-28 | Shionogi & Co Ltd | 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物 |
CO5140099A1 (es) | 1998-11-17 | 2002-03-22 | Novartis Ag | Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores |
US6239127B1 (en) * | 1999-11-17 | 2001-05-29 | Novartis Ag | Certain substituted caprolactams, pharmaceutical compositions containing them and a process for their preparation |
CA2405892C (en) * | 2000-05-11 | 2009-07-07 | Frederick Ray Kinder Jr. | Substituted caprolactam carbonates and ethers and their use as anti-tumor agents |
JP2004514122A (ja) | 2000-11-14 | 2004-05-13 | ノバルティス アクチエンゲゼルシャフト | 抗増殖性化合物をスクリーニングしかつ腫瘍増殖を阻害する方法 |
WO2002072555A1 (en) * | 2001-03-12 | 2002-09-19 | Novartis Ag | Process for preparing certain substituted caprolactams |
JP2004262793A (ja) | 2003-02-28 | 2004-09-24 | Noyaku Bio Technology Kaihatsu Gijutsu Kenkyu Kumiai | 化合物n−9011、その製造法及び用途 |
JP2006528611A (ja) * | 2003-07-25 | 2006-12-21 | ノバルティス アクチエンゲゼルシャフト | 置換ラクタムおよびそれらの抗がん剤としての使用 |
DE10349669B3 (de) | 2003-10-24 | 2005-05-25 | Aventis Pharma Deutschland Gmbh | Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
US7153846B2 (en) * | 2003-10-24 | 2006-12-26 | Sanofi-Aventis Deutschland Gmbh | Bengamide derivatives, process for preparing them, and their use |
FR2878528B1 (fr) * | 2004-11-29 | 2008-05-16 | Aventis Pharma Sa | 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation |
FR2878525B1 (fr) * | 2004-11-29 | 2007-02-23 | Aventis Pharma Sa | Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation |
-
2006
- 2006-05-24 FR FR0604735A patent/FR2901555A1/fr active Pending
-
2007
- 2007-05-17 TW TW096117613A patent/TW200812990A/zh unknown
- 2007-05-21 PE PE2007000623A patent/PE20080258A1/es not_active Application Discontinuation
- 2007-05-23 PT PT07765943T patent/PT2029596E/pt unknown
- 2007-05-23 ES ES07765943T patent/ES2341589T3/es active Active
- 2007-05-23 BR BRPI0711892-9A patent/BRPI0711892A2/pt not_active IP Right Cessation
- 2007-05-23 EA EA200870566A patent/EA200870566A1/ru unknown
- 2007-05-23 CN CNA2007800189562A patent/CN101454278A/zh active Pending
- 2007-05-23 CA CA002652361A patent/CA2652361A1/fr not_active Abandoned
- 2007-05-23 AT AT07765943T patent/ATE458738T1/de active
- 2007-05-23 SI SI200730237T patent/SI2029596T1/sl unknown
- 2007-05-23 WO PCT/FR2007/000867 patent/WO2007135294A2/fr active Application Filing
- 2007-05-23 EP EP07765943A patent/EP2029596B1/fr active Active
- 2007-05-23 AU AU2007253197A patent/AU2007253197A1/en not_active Abandoned
- 2007-05-23 MX MX2008014957A patent/MX2008014957A/es active IP Right Grant
- 2007-05-23 AR ARP070102223A patent/AR061104A1/es unknown
- 2007-05-23 PL PL07765943T patent/PL2029596T3/pl unknown
- 2007-05-23 DK DK07765943.1T patent/DK2029596T3/da active
- 2007-05-23 DE DE602007004982T patent/DE602007004982D1/de active Active
- 2007-05-23 JP JP2009511546A patent/JP2009537615A/ja not_active Withdrawn
- 2007-05-23 KR KR1020087028522A patent/KR20090010214A/ko not_active Application Discontinuation
- 2007-05-24 DO DO2007000103A patent/DOP2007000103A/es unknown
- 2007-05-24 UY UY30366A patent/UY30366A1/es not_active Application Discontinuation
-
2008
- 2008-11-04 TN TNP2008000442A patent/TNSN08442A1/en unknown
- 2008-11-06 CR CR10428A patent/CR10428A/es unknown
- 2008-11-10 US US12/267,691 patent/US7960373B2/en not_active Expired - Fee Related
- 2008-11-19 EC EC2008008897A patent/ECSP088897A/es unknown
- 2008-11-24 GT GT200800254A patent/GT200800254A/es unknown
- 2008-12-05 MA MA31453A patent/MA30560B1/fr unknown
- 2008-12-12 NO NO20085189A patent/NO20085189L/no not_active Application Discontinuation
-
2010
- 2010-05-21 CY CY20101100455T patent/CY1110089T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US7960373B2 (en) | 2011-06-14 |
SI2029596T1 (sl) | 2010-07-30 |
JP2009537615A (ja) | 2009-10-29 |
PT2029596E (pt) | 2010-05-28 |
MX2008014957A (es) | 2008-12-10 |
DE602007004982D1 (de) | 2010-04-08 |
EA200870566A1 (ru) | 2009-04-28 |
MA30560B1 (fr) | 2009-07-01 |
WO2007135294A2 (fr) | 2007-11-29 |
ATE458738T1 (de) | 2010-03-15 |
FR2901555A1 (fr) | 2007-11-30 |
BRPI0711892A2 (pt) | 2012-01-10 |
CY1110089T1 (el) | 2015-01-14 |
AU2007253197A1 (en) | 2007-11-29 |
TW200812990A (en) | 2008-03-16 |
UY30366A1 (es) | 2008-01-02 |
KR20090010214A (ko) | 2009-01-29 |
ES2341589T3 (es) | 2010-06-22 |
CN101454278A (zh) | 2009-06-10 |
US20090093459A1 (en) | 2009-04-09 |
AR061104A1 (es) | 2008-08-06 |
EP2029596A2 (fr) | 2009-03-04 |
DK2029596T3 (da) | 2010-06-14 |
CA2652361A1 (fr) | 2007-11-29 |
PL2029596T3 (pl) | 2010-07-30 |
PE20080258A1 (es) | 2008-05-12 |
ECSP088897A (es) | 2008-12-30 |
TNSN08442A1 (en) | 2010-04-14 |
WO2007135294A3 (fr) | 2008-01-17 |
GT200800254A (es) | 2009-03-13 |
DOP2007000103A (es) | 2007-11-15 |
EP2029596B1 (fr) | 2010-02-24 |
CR10428A (es) | 2008-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007008790A (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso. | |
IL228402A0 (en) | Nitro-cyclic compounds, their pharmaceutical preparations and their uses | |
IL188050A (en) | The history of azaindazole, their medicinal preparations and their uses | |
TW200630343A (en) | 2-Alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof | |
JO2721B1 (en) | Derivatives of artemisia plant and its preparations and therapeutic applications | |
TW200508197A (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
BRPI0717369A2 (pt) | Composto, medicamento, composição farmacêutica que o contém e uso do composto. | |
TW200738627A (en) | Trialkylsilyl-indoles | |
TW200744612A (en) | New combination | |
EP2125831A4 (en) | ISOFLAVONOID OXAZINYL COMPOUNDS, MEDICAMENTS AND USE | |
NO20074528L (no) | Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme | |
SE0300457D0 (sv) | Novel compounds | |
GB0615105D0 (en) | Novel compounds | |
IL193115A0 (en) | Sulfonamide derivatives, their preparation and pharmaceutical compositions containing them | |
TW200633717A (en) | Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents | |
NO20085189L (no) | 2-alkoksy-3,4,5-trihydroksy-alkylamid-benzotaizepiner, fremstilling og anvendelse derav sammensetninger inneholdende samme | |
NO20085267L (no) | Derivater av 2-alkoksy -3,4,5-trihydroksy-alkyl amider, fremstilling og anvendelse derav, samt sammensetninger inneholdende samme | |
CY1110787T1 (el) | Νεα μορφινικα παραγωγα | |
GB0620619D0 (en) | Novel compounds | |
EA200870565A1 (ru) | 2-алкокси-3,4,5-тригидроксиалкиламидобензазепины, их получение, содержащие их композиции и применение | |
MX2009009178A (es) | Bis-fosforatos de bazedoxifeno. | |
EP1994003A4 (en) | PIPERIDINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, THEIR USE AS THERAPEUTIC AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEY | |
TWI368614B (en) | Araminone compounds, their preparations, pharmaceutical compositions containing them, and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |